T cell receptor alpha variable 26-2 (TRAV26-2)

TRAV26-2 encodes the variable region of the alpha chain of the human T cell receptor (TCR), which forms a heterodimeric transmembrane receptor with the beta chain on most T lymphocytes[2][5]. The TCR complex is essential for the recognition of peptide antigens presented by MHC molecules on antigen-presenting cells, initiating T cell activation, and adaptive immunity. The alpha chain variable region, including TRAV26-2, is generated through V-J gene rearrangement during T cell development, contributing to the diversity of antigen recognition. While the whole TCR complex is a critical mediator of immune responses and may be targeted in certain immunotherapies, the TRAV26-2 segment itself is a genetic element, not an independent drug target[2][5][1]. TRAV26-2 is one of many human TCR alpha variable gene segments; its diversity supports the wide range of T cell responses but is not individually considered a receptor or therapeutic target as understood in drug discovery paradigms. Identification of clonal expansions bearing specific TRAV segments (including TRAV26-2) may provide insight into immune responses or disease states—this is primarily of research/diagnostic, not therapeutic, relevance[2][4][5].

Other names

TRAV26-2TRAV262TCRAV4S1TCRAV26S2

Null (no drugs specifically target this molecular variable segment)